LGC Capital Provides an Update on its Private Placement and Binding Letter of Intent with Creso Pharma & Baltic Beer Company

/NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES/

MONTREAL, Nov. 30, 2017 /CNW Telbec/ - LGC Capital Ltd. (TSXV: LG) ("LGC") announces that it will close its previously-announced private placement of units, at an issue price of $0.15 per unit, in an amount of $3,727,872 in order to comply with the policies of the TSX Venture Exchange relating to the pricing of private placements, rather than in an amount of approximately $4.265 million as announced by LGC on November 28, 2017. LGC expects to complete the private placement this week.

Each of the units to be issued by LGC will be comprised of one common share and one common share purchase warrant; each warrant will entitle its holder to acquire one additional LGC common share at a price of $0.25 for a period of 18 months from the closing date of the private placement. In the event that the volume weighted average trading price of LGC's shares on the TSX Venture Exchange for a period of ten consecutive trading days is at least $0.30, the warrants will expire, at the sole discretion of LGC, on the 30^th day after the date on which LGC sends a notice in prescribed form to the holders of the warrants.

The units are being offered to "accredited investors" in Canada and internationally. LGC will use the net proceeds from the private placement to meet its obligations within LGC's current cannabis investment portfolio and for working capital.

LGC also wishes to provide an update on its previously-announced binding Letter of Intent with Creso Pharma Limited (Australia and Switzerland) and Baltic Beer Company Ltd (UK), to develop and market a bespoke portfolio of cannabis and hemp-derived alcoholic and non-alcoholic beverages. The portfolio of beverages will contain various ingredients including seeds, extracts and terpenes from hemp and cannabis plants. LGC and Creso Pharma will each make an initial investment in the joint venture of € 150,000 (approximately CAD $225,000) for research and development, brand development and testing, which will be carried out by Baltic Beer. Each party will have a 33% interest in the joint venture.

About LGC Capital (http://www.lgc-capital.com)

LGC Capital Ltd. is a Canadian incorporated public company listed on the TSX Venture Exchange (TSXV: LG). LGC is a diversified investment company with core holdings in businesses that provide shareholders with exposure to a diverse range of high-growth businesses, products and services. To date, LGC has entered into agreements for investments in private cannabis operations in South Africa, Australia and Canada. LGC also has a joint venture with AfriAg (Pty) Ltd. to grow and distribute medical and recreational cannabis products in the southern African region for export to regulated and certified end users around the world, and a strategic alliance with Creso Pharma Limited for the creation of a vertically-integrated cannabis operation, which includes cultivation, IP generation, product development, and commercialization. LGC is headquartered in Montreal, Canada.

FORWARD-LOOKING STATEMENTS:

This press release may contain forward-looking statements with respect to LGC Capital Ltd. ("LGC"), its operations, strategy, investments, financial performance and condition, and the private placement and joint venture referred to above. These statements generally can be identified by use of forward-looking words such as "may", "will", "expect", "estimate", "anticipate", "intends", "believe" or "continue" or the negative thereof or similar variations. The actual results and performance of LGC or the joint venture could differ materially from those expressed or implied by such statements. Such statements are qualified in their entirety by the inherent risks and uncertainties surrounding future expectations. Some important factors that could cause actual results to differ materially from expectations include, among other things, general economic and market factors, competition, government regulation and the factors described under "Risk Factors and Risk Management" in LGC's Management's Discussion and Analysis for the fiscal year ended September 30, 2016, as filed on SEDAR (www.sedar.com). The cautionary statements qualify all forward-looking statements attributable to LGC and persons acting on its behalf. Unless otherwise stated, all forward-looking statements speak only as of the date of this press release and LGC has no obligation to update such statements, except to the extent required by applicable securities laws.

Caution Regarding Press Releases:

Neither the TSX Venture Exchange nor its Regulation Service Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

SOURCE LGC Capital Ltd

Company & Media Contacts: Canada contact: John McMullen, Chief Executive Officer, Tel.: [phone], Email: [email protected]; London contact: Anthony Samaha, Chief Financial Officer, Tel.: [phone]; Investor Relations contact: Dave Burwell, The Howard Group Inc., Tel.: [phone], Toll Free: 1-888-221-0915, Email: [email protected]